Flow is designed to treat mild to moderate depressive symptoms and has been approved for use for people over 18 years of age who have been diagnosed with depression (Major Depressive Disorder).
This approval is based on multiple research studies that confirm the safety and efficacy of using the tDCS technology used in Flow for treating depression in this group of people. It has been found that the Flow device poses minimal risk of injury. It’s important to contact a healthcare professional and receive a diagnosis before using Flow.
Whilst the Flow device does not require a prescription, it is recommended to consider multiple treatment options and consult your healthcare professional before undergoing any changes to your treatment. Read more about Safety & Precautions.